2024-04-08 12:15 | CC:IGX | IntelGenx Technologies Corp | 0.24 | News Release200 | IntelGenx doses 1st PD patients in Montelukast trial |
2024-04-05 10:18 | CC:IGX | IntelGenx Technologies Corp | 0.26 | News Release200 | IntelGenx partner Chemo receives FDA response letter |
2024-03-21 10:37 | CC:IGX | IntelGenx Technologies Corp | 0.21 | News Release200 | IntelGenx loses $10.1-million (U.S.) in fiscal 2023 |
2024-03-21 09:13 | CC:IGX | IntelGenx Technologies Corp | 0.21 | SEDAR MD & A815 | SEDAR MD & A |
2024-03-21 08:15 | CC:IGX | IntelGenx Technologies Corp | 0.21 | SEDAR Annual Report803 | SEDAR Annual Report |
2024-03-21 08:15 | CC:IGX | IntelGenx Technologies Corp | 0.21 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2024-03-14 16:39 | CC:IGX | IntelGenx Technologies Corp | 0.225 | News Release200 | IntelGenx Technologies to release 2023 results March 21 |
2024-03-11 10:55 | CC:IGX | IntelGenx Technologies Corp | 0.225 | News Release200 | IntelGenx unit adds two $1M (U.S.) loans to atai loan |
2024-02-20 09:16 | CC:IGX | IntelGenx Technologies Corp | 0.195 | News Release200 | IntelGenx arranges $20-million Regulation A offering |
2024-02-05 11:32 | CC:IGX | IntelGenx Technologies Corp | 0.215 | News Release200 | IntelGenx talks positive VetaFilm POC results |
2023-12-18 10:48 | CC:IGX | IntelGenx Technologies Corp | 0.17 | News Release200 | IntelGenx teams with Covenant for Vetafilm development |
2023-12-05 12:30 | CC:IGX | IntelGenx Technologies Corp | 0.21 | News Release200 | IntelGenx closes $750,000 (U.S.) private placement |
2023-12-04 11:28 | CC:IGX | IntelGenx Technologies Corp | 0.18 | News Release200 | IntelGenx shuffles board of directors |
2023-11-28 16:28 | CC:IGX | IntelGenx Technologies Corp | 0.205 | News Release200 | IntelGenx shareholders approve financing transactions |
2023-11-14 11:00 | CC:IGX | IntelGenx Technologies Corp | 0.165 | News Release200 | IntelGenx to study Versafilm for Parkinson's treatment |
2023-11-13 12:05 | CC:IGX | IntelGenx Technologies Corp | 0.165 | News Release200 | IntelGenx reminds holders to vote at special meeting |
2023-11-09 16:46 | CC:IGX | IntelGenx Technologies Corp | 0.195 | News Release200 | IntelGenx loses $2.5-million (U.S.) in Q3 2023 |
2023-11-09 16:15 | CC:IGX | IntelGenx Technologies Corp | 0.195 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-11-09 16:13 | CC:IGX | IntelGenx Technologies Corp | 0.195 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-11-06 12:52 | CC:IGX | IntelGenx Technologies Corp | 0.185 | News Release200 | IntelGenx receives purchase order from Tilray |
2023-11-02 16:54 | CC:IGX | IntelGenx Technologies Corp | 0.185 | News Release200 | IntelGenx to release Q3 2023 results Nov. 9 |
2023-09-21 10:12 | CC:IGX | IntelGenx Technologies Corp | 0.18 | News Release200 | IntelGenx receives RizaFilm PO from Gensco Pharma |
2023-09-19 12:47 | CC:IGX | IntelGenx Technologies Corp | 0.185 | News Release200 | IntelGenx receives ANDA amendment priority review |
2023-08-31 12:34 | CC:IGX | IntelGenx Technologies Corp | 0.20 | News Release200 | IntelGenx closes $3M (U.S.) 1st financing tranche |
2023-08-14 16:47 | CC:IGX | IntelGenx Technologies Corp | 0.255 | News Release200 | IntelGenx Technologies loses $3-million (U.S.) in Q2 |
2023-08-14 16:25 | CC:IGX | IntelGenx Technologies Corp | 0.255 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-10 16:49 | CC:IGX | IntelGenx Technologies Corp | 0.225 | News Release200 | IntelGenx to provide pharma packaging for CDMO |
2023-08-08 03:53 | CC:IGX | IntelGenx Technologies Corp | 0.225 | News Release200 | IntelGenx to release Q2 results, host call Aug. 14 |
2023-08-01 10:39 | CC:IGX | IntelGenx Technologies Corp | 0.23 | News Release200 | IntelGenx completes patient enrolment for Buena trial |
2023-07-25 13:27 | CC:IGX | IntelGenx Technologies Corp | 0.20 | News Release200 | IntelGenx signs research grant deal with uni hospital |
2023-07-21 16:36 | CC:IGX | IntelGenx Technologies Corp | 0.21 | News Release200 | IntelGenx director, vice-chairman Boudreau resigns |
2023-07-06 16:39 | CC:IGX | IntelGenx Technologies Corp | 0.26 | News Release200 | IntelGenx shareholders approve all matters at AGM |
2023-05-31 13:15 | CC:IGX | IntelGenx Technologies Corp | 0.205 | News Release200 | IntelGenx talks short-term revenue plan |
2023-05-17 12:12 | CC:IGX | IntelGenx Technologies Corp | 0.18 | News Release200 | IntelGenx receives amended drug establishment licence |
2023-05-11 17:48 | CC:IGX | IntelGenx Technologies Corp | 0.20 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-11 17:48 | CC:IGX | IntelGenx Technologies Corp | 0.20 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-11 17:29 | CC:IGX | IntelGenx Technologies Corp | | News Release200 | IntelGenx Technologies loses $2.9-million (U.S.) in Q1 |
2023-05-04 17:32 | CC:IGX | IntelGenx Technologies Corp | | News Release200 | IntelGenx Technologies to release Q1 results May 11 |